350 related articles for article (PubMed ID: 28463538)
1. Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer Treatment.
Jadvar H
AJR Am J Roentgenol; 2017 Aug; 209(2):277-288. PubMed ID: 28463538
[TBL] [Abstract][Full Text] [Related]
2. [Radionuclide therapy for cancer--what's new?].
Hanna M; Mikko T
Duodecim; 2012; 128(21):2209-16. PubMed ID: 23210283
[TBL] [Abstract][Full Text] [Related]
3. Radionuclide therapy beyond radioiodine.
Gabriel M
Wien Med Wochenschr; 2012 Oct; 162(19-20):430-9. PubMed ID: 22815123
[TBL] [Abstract][Full Text] [Related]
4. [Nuclear medicine in oncotherapy].
Pávics L; Besenyi Z
Magy Onkol; 2015 Sep; 59(3):193-7. PubMed ID: 26339908
[TBL] [Abstract][Full Text] [Related]
5. Whole-body iodine-131 metaiodobenzylguanidine imaging for detection of bone metastases in patients with paraganglioma: comparison with bone scintigraphy.
Inoue T; Yoshinaga K; Morita K; Shiga T; Kanegae K; Hirata K; Okamoto S; Tamaki N
Ann Nucl Med; 2007 Jul; 21(5):307-10. PubMed ID: 17634850
[TBL] [Abstract][Full Text] [Related]
6. Radiotheranostics - Precision Medicine in Nuclear Medicine and Molecular Imaging.
Duan H; Iagaru A; Aparici CM
Nanotheranostics; 2022; 6(1):103-117. PubMed ID: 34976584
[TBL] [Abstract][Full Text] [Related]
7. Radionuclide Therapies: An Overview of Applications.
Smith RJ; Burpee D
Radiol Technol; 2021 Jul; 92(6):595-614. PubMed ID: 34193577
[TBL] [Abstract][Full Text] [Related]
8. Radionuclide Therapies in Molecular Imaging and Precision Medicine.
Kendi AT; Moncayo VM; Nye JA; Galt JR; Halkar R; Schuster DM
PET Clin; 2017 Jan; 12(1):93-103. PubMed ID: 27863570
[TBL] [Abstract][Full Text] [Related]
9. Intraarterial 131I-MIBG therapy of neuroendocrine tumors with liver metastases.
Popp M; Strumpf A; Zöphel K; Stroszczynski C; Kotzerke J
Nuklearmedizin; 2010; 49(1):N2-3. PubMed ID: 20336828
[No Abstract] [Full Text] [Related]
10. Recent advances in nuclear medicine in endocrine oncology.
Luster M; Pfestroff A; Verburg FA
Curr Opin Oncol; 2017 Jan; 29(1):1-6. PubMed ID: 27906859
[TBL] [Abstract][Full Text] [Related]
11. Radioligand Theranostics in the Management of Neuroendocrine Tumors.
Harris AG; Vinik AI; OʼDorisio TM; OʼDorisio MS
Pancreas; 2020; 49(5):599-603. PubMed ID: 32433395
[No Abstract] [Full Text] [Related]
12. Somatostatin imaging of neuroendocrine-differentiated prostate cancer.
Hope TA; Aggarwal R; Simko JP; VanBrocklin HF; Ryan CJ
Clin Nucl Med; 2015 Jun; 40(6):540-1. PubMed ID: 25783510
[TBL] [Abstract][Full Text] [Related]
13. An Impressive Approach in Nuclear Medicine: Theranostics.
Vahidfar N; Eppard E; Farzanehfar S; Yordanova A; Fallahpoor M; Ahmadzadehfar H
PET Clin; 2021 Jul; 16(3):327-340. PubMed ID: 34053577
[TBL] [Abstract][Full Text] [Related]
14. Patient selection for personalized peptide receptor radionuclide therapy using Ga-68 somatostatin receptor PET/CT.
Kulkarni HR; Baum RP
PET Clin; 2014 Jan; 9(1):83-90. PubMed ID: 25029937
[TBL] [Abstract][Full Text] [Related]
15. [Nuclear medicine therapy of bone metastases].
Kimmig B; Hermann HJ; Kober B
Rontgenblatter; 1983 Jul; 36(7):216-9. PubMed ID: 6622951
[TBL] [Abstract][Full Text] [Related]
16. Challenging cases in thyroid cancer: a multidisciplinary approach.
Tuttle M; Robbins R; Larson SM; Strauss HW
Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):605-12. PubMed ID: 14666383
[TBL] [Abstract][Full Text] [Related]
17. Radioembolization for treatment of liver metastases from neuroendocrine tumors: correlation with imaging and biomarkers.
Ozao-Choy J; Friedman ML; Kim AS; Wachsman A; Wolin EM; Yu R; Nissen NN; Colquhoun SD
Pancreas; 2013 Mar; 42(2):358-60. PubMed ID: 23407486
[No Abstract] [Full Text] [Related]
18. Tumor imaging and therapy using radiolabeled somatostatin analogues.
de Jong M; Breeman WA; Kwekkeboom DJ; Valkema R; Krenning EP
Acc Chem Res; 2009 Jul; 42(7):873-80. PubMed ID: 19445476
[TBL] [Abstract][Full Text] [Related]
19. Proceedings of the Second NCI-SNMMI Workshop on Targeted Radionuclide Therapy.
Fahey F; Zukotynski K; Jadvar H; Capala J;
J Nucl Med; 2015 Jul; 56(7):1119-29. PubMed ID: 25999432
[No Abstract] [Full Text] [Related]
20. Osseous metastases of gastro-enteropancreatic neuroendocrine tumours. Diagnostic value of intra-therapeutic 177Lu-octreotate imaging in comparison with bone scintigraphy.
Sabet A; Ezziddin S; Heinemann F; Guhlke S; Muckle M; Willinek W; Biersack HJ; Ahmadzadehfar H
Nuklearmedizin; 2012; 51(3):95-100. PubMed ID: 22421930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]